WHO relaunches global drug trial with three new candidates. | Science;373(6555): 606-607, 2021 08 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

WHO relaunches global drug trial with three new candidates.

Kupferschmidt, Kai.

Science ; 373(6555): 606-607, 2021 08 06.

Article in English | MEDLINE | ID: covidwho-1352513

Subject(s)

Artesunate/therapeutic use; COVID-19 Drug Treatment; Imatinib Mesylate/therapeutic use; Infliximab/therapeutic use; World Health Organization; Antiviral Agents/therapeutic use; Humans; Randomized Controlled Trials as Topic

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: World Health Organization / Imatinib Mesylate / Infliximab / Artesunate / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Science Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: World Health Organization / Imatinib Mesylate / Infliximab / Artesunate / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Science Year: 2021 Document Type: Article